Oxytocin in metabolic homeostasis: implications for obesity and diabetes management
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Summary: Oxytocin was once understood solely as a neuropeptide with a central role in social bonding, reproduction, parturition, lactation and appetite regulation. Recent evidence indicates that oxytocin enhances glucose uptake and lipid utilization in adipose tissue and skeletal muscle, suggesting that dysfunction of the oxytocin system could underlie the pathogenesis of insulin resistance and dyslipidaemia. Murine studies revealed that deficiencies in oxytocin signalling and oxytocin receptor expression lead to obesity despite normal food intake, motor activity and increased leptin levels. In addition, plasma oxytocin concentration is notably lower in obese individuals with diabetes, which may suggest an involvement of the oxytocin system in the pathogenesis of cardiometabolic disease. More recently, small scale studies demonstrated that intranasal administration of oxytocin was associated with significant weight loss as well as improvements in insulin sensitivity and pancreatic β‐cell responsivity in human subjects. The multi‐pronged effects of oxytocin signalling on improving peripheral insulin sensitivity, pancreatic function and lipid homeostasis strongly suggest a role for this system as a therapeutic target in obesity and diabetes management. The complexity of obesity aetiology and the pathogenesis of obesity‐related metabolic complications underscore the need for a systems approach to better understand the role of oxytocin in metabolic function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484 · cited 4×
“Oxytocin-mediated reduction of WAT macrophage infiltration (52) may also remediate obesity-associated lipolysis in WAT and increase hepatic TG synthesis from enhanced fatty acid esterification (51).”
BackgroundInfluentialChronic stress and obesity: a new view of “comfort food”
Dallman, M. F., Pecoraro, N., Akana, S. F., la Fleur, S. E., Gomez, F., Houshyar, H., Bell, M. E., Bhatnagar, S., Laugero, K. D., & Manalo, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934666100 · Cited by 1,369 · cited 1×
“atable snack intake and concomitant reduction of hormones related to basal corticotropic function and hypothalamic–pituitary–adrenal axis activity strongly suggest a role for oxytocin in suppressing the activity of endocrine stress axes (activation of which increases the salience of pleasurable or compulsive activitie…”
BackgroundOn some physiological actions of ergot
Dale, H. H. (1906) · The Journal of Physiology · doi:10.1113/jphysiol.1906.sp001148 · Cited by 1,011
The sexual dimorphism of obesity
Palmer, B. F., & Clegg, D. J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.029 · Cited by 919 · cited 1×
“Moreover, sexual dimorphism has also long been observed in the pathophysiology of diabetes and obesity (137).”
BackgroundIntranasal Oxytocin: Myths and Delusions
Leng, G., & Ludwig, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.003 · Cited by 616 · cited 4×
“tion studies) (114) may lead to competitive inhibition, altering the binding of vasopressin to its specific receptors.”
BackgroundInfluentialEffects of intranasal oxytocin on emotional face processing in women
Domes, G., Lischke, A., Berger, C., Grossmann, A., Hauenstein, K., Heinrichs, M., & Herpertz, S. C. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.016 · Cited by 521 · cited 1×
“It has been demonstrated that intranasal oxytocin differentially activates brain networks involved in social and emotional information processing in women when compared with men, suggesting important sexual differences in the central effects of oxytocin (136).”
BackgroundFeldman, R., Gordon, I., & Zagoory‐Sharon, O. (2011) · Developmental Science · doi:10.1111/j.1467-7687.2010.01021.x · Cited by 486 · cited 1×
“However, the validity of urinary oxytocin as a proxy for peripheral oxytocin concentrations is still a matter of dispute (104,105).”
BackgroundInhibition of oxytocin receptor function by direct binding of progesterone
Grazzini, E., Guillon, G., Mouillac, B., & Zingg, H. H. (1998) · Nature · doi:10.1038/33176 · Cited by 466 · cited 1×
“Data from transfection studies also suggest progesterone may inhibit binding of oxytocin to human OTR (40).”
BackgroundStriepens, N., Kendrick, K. M., Hanking, V., Landgraf, R., Wüllner, U., Maier, W., & Hurlemann, R. (2013) · Scientific Reports · doi:10.1038/srep03440 · Cited by 452 · cited 2×
“ship to gender, BMI or metabolic health status (13,100,102,123,127,138).”
BackgroundProblems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted?
McCullough, M. E., Churchland, P. S., & Mendez, A. J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.018 · Cited by 416
Elabd, C., Cousin, W., Upadhyayula, P., Chen, R. Y., Chooljian, M. S., Li, J., Kung, S., Jiang, K. P., & Conboy, I. M. (2014) · Nature Communications · doi:10.1038/ncomms5082 · Cited by 411
A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research
MacDonald, E., Dadds, M. R., Brennan, J. L., Williams, K., Levy, F., & Cauchi, A. J. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.02.015 · Cited by 359 · cited 1×
“In addition, oxytocin administered intranasally has so far demonstrated significant central effects accompanied with an excellent safety profile with minimal side effects and adverse reactions (141).”
BackgroundInnervation Patterns of Autonomic Axons in the Human Endocrine Pancreas
Rodriguez-Diaz, R., Abdulreda, M. H., Formoso, A. L., Gans, I., Ricordi, C., Berggren, P.-O., & Caicedo, A. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.05.008 · Cited by 356
Influence of oxytocin on feeding behavior in the rat
Arletti, R., Benelli, A., & Bertolini, A. (1989) · Peptides · doi:10.1016/0196-9781(89)90082-x · Cited by 328
Structural bases of vasopressin/oxytocin receptor function
Barberis, C., Mouillac, B., & Durroux, T. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560223 · Cited by 311 · cited 2×
“Molecular cloning experiments have confirmed that the human OTR is a member of the rhodopsin-type class I G-protein-coupled receptor superfamily, characterised by seven hydrophobic transmembrane α-helices joined by alternating intracellular and extracellular loops, with an extracellular N-terminal domain and a cytopla…”
BackgroundMechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats
Deblon, N., Veyrat-Durebex, C., Bourgoin, L., Caillon, A., Bussier, A.-L., Petrosino, S., Piscitelli, F., Legros, J.-J., Geenen, V., Foti, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025565 · Cited by 254 · cited 7×
“Acetyl-coenzyme A carboxylase α (Acaca) No change (82)”
BackgroundInfluentialMeasuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers
Leng, G., & Sabatier, N. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12413 · Cited by 237 · cited 1×
“OT-like immunoreactivity (101) and heterophilic interference (139) have been suggested as possible reasons for the apparent inconsistencies in data.”
ResultLow sympathetic tone and obese phenotype in oxytocin-deficient mice
Camerino, C. (2009) · Obesity · doi:10.1038/oby.2009.12 · Cited by 235 · cited 1×
“In support of this hypothesis, decreased insulin sensitivity and impaired glucose tolerance were found in oxytocin-deficient (Oxt / ) and high fat diet-fed OTR-deficient (Oxtr / ) mice (78,79).”
BackgroundOxytocin Reduces Reward-Driven Food Intake in Humans
Ott, V., Finlayson, G., Lehnert, H., Heitmann, B., Heinrichs, M., Born, J., & Hallschmid, M. (2013) · Diabetes · doi:10.2337/db13-0663 · Cited by 226
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models
Zhang, H., Wu, C., Chen, Q., Chen, X., Xu, Z., Wu, J., & Cai, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061477 · Cited by 224 · cited 2×
“(86), four times daily intranasal oxytocin (24 IU) in nine Asian men and women with obesity 32 Oxytocin and metabolism C.”
BackgroundPeripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass
Maejima, Y., Iwasaki, Y., Yamahara, Y., Kodaira, M., Sedbazar, U., & Yada, T. (2011) · Aging · doi:10.18632/aging.100408 · Cited by 220 · cited 3×
“NEFAs may also be channelled to β-oxidation, which could underlie the decreased respiratory quotient (RQ) observed in oxytocintreated DIO rodents and healthy men (13,80,82).”
BackgroundOxytocin reduces caloric intake in men
Lawson, E. A., Marengi, D. A., DeSanti, R. L., Holmes, T. M., Schoenfeld, D. A., & Tolley, C. J. (2015) · Obesity · doi:10.1002/oby.21069 · Cited by 208 · cited 7×
“NEFAs may also be channelled to β-oxidation, which could underlie the decreased respiratory quotient (RQ) observed in oxytocintreated DIO rodents and healthy men (13,80,82).”
BackgroundInfluentialZhang, G., Bai, H., Zhang, H., Dean, C., Wu, Q., Li, J., Guariglia, S., Meng, Q., & Cai, D. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.036 · Cited by 208
Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis
Elabd, C., Basillais, A., Beaupied, H., Breuil, V., Wagner, N., Scheideler, M., Zaragosi, L.-E., Massiéra, F., Lemichez, E., Trajanoski, Z., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0127 · Cited by 202 · cited 2×
“In one study, both oxytocin and carbotocin (a stable oxytocin analogue) dose-dependently inhibited adipocyte differentiation in human multipotent adipose-derived stem cells (88).”
BackgroundIntranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study
Cardoso, C., Ellenbogen, M. A., Orlando, M. A., Bacon, S. L., & Joober, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.07.013 · Cited by 187
Zhang, G., & Cai, D. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00196.2011 · Cited by 171
Ishunina, T. A., & Swaab, D. F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6187 · Cited by 132 · cited 1×
“A postmortem study on oxytocin neurons in the human paraventricular nucleus showed that oxytocin neuron size (an indicator of neuron activity) does not change with age (109).”
BackgroundÅkerlund, M., Bossmar, T., Brouard, R., Kostrzewska, A., Laudanski, T., Lemancewicz, A., Gal, C. S., & Steinwall, M. (1999) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08112.x · Cited by 123
Role of oxytocin signaling in the regulation of body weight
Blevins, J. E., & Ho, J. M. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9260-x · Cited by 108
Fabian, M., Forsling, M. L., Jones, J. J., & Pryor, J. S. (1969) · The Journal of Physiology · doi:10.1113/jphysiol.1969.sp008937 · Cited by 107 · cited 1×
“8 min during a 500 mU min 1 infusion (22).”
BackgroundAMICO, J. A., ULBRECHT, J. S., & ROBINSON, A. G. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-2-340 · Cited by 105
Role of oxytocin in energy metabolism
Chaves, V. E., Tilelli, C. Q., Brito, N. A., & Brito, M. N. (2013) · Peptides · doi:10.1016/j.peptides.2013.04.010 · Cited by 90
Mechsner, S., Bartley, J., Loddenkemper, C., Salomon, D. S., Starzinski-Powitz, A., & Ebert, A. D. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.038 · Cited by 79 · cited 1×
“Human endometriosis cell line (12Z) + (146)”
Borg, J., Simrén, M., & Ohlsson, B. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01599.x · Cited by 26 · cited 1×
“In contrast, 40 mUmin 1 intravenous oxytocin infusion in 10 healthy men and women reduced satiety levels without affecting the volume of a liquid meal consumed (113).”
BackgroundNakamura, K., Fujiwara, Y., Mizutani, R., Sanbe, A., Miyauchi, N., Hiroyama, M., Yamauchi, J., Yamashita, T., Nakamura, S., Mori, T., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1528 · Cited by 25 · cited 2×
“Evidence suggests that oxytocin reduces ACTH and cortisol production by competing with vasopressin for V1b receptors in the anterior pituitary – at equimolar concentrations, the stimulation of ACTH production by oxytocin was shown to be reduced in comparison with stimulation with vasopressin (130).”
Result
Cited by
Buemann, B., & Uvnäs-Moberg, K. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109597 · Cited by 66
Engel, S., Laufer, S., Miller, R., Niemeyer, H., Knaevelsrud, C., & Schumacher, S. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100775 · Cited by 50
Oxytocin: an expansive review of its mechanisms, functions, and therapeutic potential
Ueda, Y. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.19.1.1499 · Cited by 5
Metadata
- Authors
- Ding, C., Leow, M. K. ‐., & Magkos, F.
- Venue
- Obesity Reviews
- Publisher
- Wiley
- Published
- 2018-09-25
- Volume
- 20
- Issue
- 1
- Pages
- 22-40
- ISSN
- 1467-7881 (ISSN-L)
- 1467-789X
- OpenAlex
- W2893973202
- Cited by
- 111
- References
- 37
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.